biopharmaceuticals

Banner image with text: 'Stay informed with the latest IP news' and the following words listed: Insights, Interviews, Webinars.

Affibody molecule: A molecule that can detect breast cancer

By AWA | Posted on October 31, 2018

Every month is breast cancer awareness month for Swedish Biopharmaceutical R&D company Affibody, which has developed unique molecular technologies to localise cancerous tumours and individualise drug treatment for patients Director of Alliance and IP Management at Affibody Caroline Ekblad has been with the Solna based company since 2007. She started out working with research, but...

Read more : Affibody molecule: A molecule that can detect breast cancer

Filed under: Interviews

Tags: Affibody, Albumod, biopharmaceuticals, breast cancer, cancer, diagnostics, Intellectual Property, molecules, patents

Recent contributors

Ylva Strandberg, Counsel and AU and NZ Patent Attorney, Stockholm, Sweden

Ylva Strandberg

Counsel, AU and NZ Patent Attorney

Hongyue Li, Senior Associate and China Patent Attorney, Beijing, China

Hongyue Li

Senior Associate, China Patent Attorney

Isa Böttiger, Associate and Attorney at Law, Stockholm, Sweden

Isa Böttiger

Associate, Attorney at Law

Ylva Wikmark, Counsel and European Patent Attorney, Stockholm, Sweden

Ylva Wikmark

Counsel, European Patent Attorney

Ashley Zhao, Partner and Attorney at Law, Beijing, China

Ashley Zhao

Partner, Attorney at Law, Business Area Manager

Alexandre Theodorou, Partner and European Patent Attorney, Brussels, Belgium

Alexandre Theodorou

Partner, European Patent Attorney